BROOKLINE, MASS. (WHDH) - Local teenagers participating in a trial for Moderna’s vaccine said they hope that dose becoming available for youths will encourage more adolescents to get vaccinated.
The Cambridge-based company broke up their trial into two parts, where children first received vaccine shots four weeks apart. The company plans to go to the FDA for approval in a matter of weeks.
“I remember when we heard the news everyone was already booking appointments. Some of them were definitely a little bit nervous, and as someone who’s also very scared of needles, I just reassured them that the symptoms I felt, which were quite mild, only lasted a day,” said Brookline teenager Zoe Campbell, who participated in the trial.
(Copyright (c) 2024 Sunbeam Television. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed.)